Muutke küpsiste eelistusi

E-raamat: Tumor Necrosis Factor: Methods and Protocols

Edited by , Edited by
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 110,53 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Tumor necrosis factor (TNF)-? is a pleiotropic cytokine involved in a va- ety of physiological and pathological processes. After initial discovery of its ability to induce cell death and animal cachexia, it was soon realized that this cytokine played pivotal roles in the regulation of homeostasis and inflam- tory-immune responses. This led to an explosion of interest in basic and tra- lational research activities on the role of TNF in many diseases, such as cancer, septic shock, rheumatoid arthritis, and infectious diseases of the central n- vous system. Because of its potential therapeutic value, many academic and industrial research groups have worked to discover compounds that can block its activity. These studies have led to the approval of anti-TNF antibodies and soluble TNF receptors for the therapy of rheumatoid arthritis and Crohn's d- ease. TNF also can be an attractive anticancer agent capable of damaging tum- associated vessels and of inducing tumor necrosis in patients. The unique properties of TNF have led to its registration as a drug for locoregional tre- ment of sarcomas of the extremities, and stimulated many preclinical studies aimed at improving its therapeutic index for systemic use. Tumor Necrosis Factor: Methods and Protocols provides an overview of basic and translational research along with a series of practical procedures on TNF production, characterization, mutagenesis, detection in biological spe- mens, as well as several in vitro assays and animal models for studying the role of TNF in various diseases.

Arvustused

"...offers molecular and cellular biologists, pharmacologists, and toxicologists a diverse set of productive, cutting-edge tools for illuminating pathophysiological roles of TNF in disease and for identifying new drugs." - Tumori

Muu info

Springer Book Archives
Tumor Necrosis Factor as a Pharmacological Target.- Production and Characterization of Recombinant Human and Murine TNF.- Purification of TNF Binding Proteins.- Production and Characterization of Receptor-Specific TNF Muteins.- TNF? Promoter Polymorphisms.- Detection of TNF and TNF Receptor mRNA in Cells and Tissues.- Immunohistochemical Localization of TNF? and Its Receptors in the Rodent Central Nervous System.- TNF Signaling.- More Than One Way to Die.- Assessment of TNF?-Induced Endothelial Damage Through the Loss of Its Barrier Function.- Genetic Engineering in the Mouse.- TNF? in Experimental Diseases of the CNS.- In Vivo Vascular Leakage Assay.- Animal Models of Endotoxic Shock.- Collagen-Induced Arthritis as a Model for Rheumatoid Arthritis.- Myocardial Infarction.- Tumor Vascular Therapy With TNF.- Strategies for Improving the Anti-Neoplastic Activity of TNF by Tumor Targeting.